Pages that link to "Q67923126"
Jump to navigation
Jump to search
The following pages link to Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes (Q67923126):
Displaying 50 items.
- Efficient activation of nucleoside phosphoramidites with 4,5-dicyanoimidazole during oligonucleotide synthesis (Q24546297) (← links)
- Crystal structure of an RNA aptamer bound to thrombin (Q24652403) (← links)
- Redesigned and chemically-modified hammerhead ribozymes with improved activity and serum stability (Q24803677) (← links)
- In vitro selection using modified or unnatural nucleotides (Q26864079) (← links)
- The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome (Q27000201) (← links)
- Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy (Q27025832) (← links)
- Unexpected origins of the enhanced pairing affinity of 2'-fluoro-modified RNA (Q27666384) (← links)
- Synthesis and Antisense Properties of Fluoro Cyclohexenyl Nucleic Acid (F-CeNA), a Nuclease Stable Mimic of 2′-Fluoro RNA (Q27679106) (← links)
- A purification method for a molecular complex in which a scaffold molecule is fully loaded with heterogeneous molecules (Q28544434) (← links)
- Fit for the Eye: Aptamers in Ocular Disorders (Q28828283) (← links)
- RNA substrate binding site in the catalytic core of the Tetrahymena ribozyme (Q30311412) (← links)
- 2'-Fluoro RNA shows increased Watson-Crick H-bonding strength and stacking relative to RNA: evidence from NMR and thermodynamic data (Q30572953) (← links)
- HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture (Q30953558) (← links)
- In vitro selection of high-affinity nucleic acid ligands to parasite target molecules. (Q31007260) (← links)
- RNaseCut: a MALDI mass spectrometry-based method for SNP discovery (Q31136151) (← links)
- Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry (Q32038821) (← links)
- Combinatorial drug discovery: which methods will produce the greatest value? (Q32060521) (← links)
- Selection, design, and characterization of a new potentially therapeutic ribozyme (Q32067536) (← links)
- RNA aptamers as reversible antagonists of coagulation factor IXa. (Q33344114) (← links)
- Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology. (Q33492343) (← links)
- The smart targeting of nanoparticles (Q33593665) (← links)
- Function and biological applications of catalytic nucleic acids (Q33597455) (← links)
- Aptamers and the next generation of diagnostic reagents (Q33615065) (← links)
- Isolation of virus-neutralizing RNAs from a large pool of random sequences (Q33704732) (← links)
- Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function. (Q33751872) (← links)
- Efficient silencing of gene expression by an ASON-bulge-DNAzyme complex (Q33872170) (← links)
- Molecular mechanisms of action of antisense drugs (Q33916100) (← links)
- Therapeutic RNA and DNA enzymes (Q34047166) (← links)
- A general RNA motif for cellular transfection (Q34123063) (← links)
- siRNAs: applications in functional genomics and potential as therapeutics (Q34310668) (← links)
- Current status of ribozymes as gene therapy agents for cancer (Q34311089) (← links)
- In vivo activity of nuclease-resistant siRNAs (Q34365687) (← links)
- Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. (Q34366417) (← links)
- Total chemical synthesis of a ribozyme derived from a group I intron (Q34469931) (← links)
- Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers. (Q34473279) (← links)
- Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease (Q34499843) (← links)
- Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging (Q34520490) (← links)
- Effects of helical structures formed by the binding arms of DNAzymes and their substrates on catalytic activity (Q34670812) (← links)
- An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein (Q34758890) (← links)
- Formation of sheared G:A base pairs in an RNA duplex modelled after ribozymes, as revealed by NMR. (Q34858324) (← links)
- Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials (Q34979624) (← links)
- Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 (Q34981750) (← links)
- Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages (Q34985249) (← links)
- Developments in RNA chemistry, a personal view (Q35012309) (← links)
- NMR studies of G:A mismatches in oligodeoxyribonucleotide duplexes modelled after ribozymes (Q35018929) (← links)
- Design and specificity of hammerhead ribozymes against calretinin mRNA. (Q35020155) (← links)
- Effects of 2'-O-methyl nucleotide substitution on EcoRI endonuclease cleavage activities (Q35032359) (← links)
- Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents (Q35309726) (← links)
- Antiviral therapy for human immunodeficiency virus infections (Q35366050) (← links)
- Nucleic Acid Aptamers as Tools and Drugs: Recent Developments (Q35549348) (← links)